Azaindazoles useful as inhibitors of kinases

Details for Australian Patent Application No. 2006315436 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Knegtel, Ronald; Brenchley, Guy; Ramaya, Shar; Sadiq, Shazia; Durrant, Steven; Cao, Jingrong; Charrier, JeanDamien

Agent Cullen & Co

Pub. Number AU-A-2006315436

PCT Pub. Number WO2007/059219

Priority 60/737,105 15.11.05 US

Filing date 15 November 2006

Wipo publication date 24 May 2007

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

29 May 2008 PCT application entered the National Phase

  PCT publication WO2007/059219 Priority application(s): WO2007/059219

25 September 2008 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Knegtel, Ronald; Brenchley, Guy; Ramaya, Sharn; Sadiq, Shazia; Durrant, Steven; Cao, Jingrong and Charrier, Jean-Damien

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006315438-Hepatitis C virus variants

2006315428-Methods of treating fibrosing diseases by induction of immune tolerance